Work

Real-world clinical outcome of sacituzumab govitecan (SG) in HER2-negative metastatic breast cancer.

Year: 2025

Type: conference-abstract

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e13047

Authors: Yuan Yuan, Jiayi Tan, David Lin, Yeonjoo Choi, Philomena McAndrew, Dorothy J. Park, Niki Himat Tank, Mary El-Masry, Natasha Banerjee, Jin Sun Bitar

Institution: Cedars-Sinai Medical Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410820631

Cites:

Cited by:

Related to: 10